ARCHIMED is an independent investment firm specialized in the Healthcare industry. ARCHIMED is a strategic and financial partner to European and North American companies operating in the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Consumer Health, Public Safety and Care Services sectors. ARCHIMED's international team comprises of individuals with investment, medical, scientific, technological and operational experiences. ARCHIMED works alongside healthcare entrepreneurs to accelerate their business growth, through internationalization, product and service range expansions as well as capacity extension, both organically (innovation) and through acquisitions. ARCHIMED's partnering companies and entrepreneurs leverage ARCHIMED's industry networks throughout the world. Over the last thirty years, ARCHIMED's leadership team has directly managed and invested in over forty small, medium and large-size healthcare companies throughout the world. ARCHIMED is committed to the improvement of Health outcomes both through its support for the Healthcare industry and through the EURÊKA Foundation, which is a direct beneficiary of its returns on investment.
Denis has over 20 years of experience in the Healthcare sector. Denis started his career as a veterinarian and subsequently worked for AT Kearney as a consultant. In 2001, Denis joined Private Equity leader 3i as head of the Healthcare team, managing the company’s investments and portfolio assets across Europe, North America and Asia. Denis has actively contributed to the development and strategic growth of companies in various Healthcare sectors. He has served as a Board Member for over 15 public and private healthcare companies, including Quintiles, Labco, iPP, Vétoquinol, Neftys Pharma, Carso, Bioprofile and Cair. Denis is a member of the Healthcare taskforce of the Institut Montaigne, a pioneering independent French think tank. Denis is a Founding Partner of ARCHIMED. He is also a Director of the EURÊKA Foundation, ARCHIMED'S charitable foundation. Denis graduated from Vet Agro Sup, the French Veterinary University of Lyon and holds an MBA from HEC Paris. Denis speaks fluent English.
Vincent holds over 15 years experience in the Healthcare and Private Equity sectors. Vincent started his career at Bain & Company as a consultant before joining 3i’s Healthcare team. Prior to joining ARCHIMED, Vincent was the Managing Director of JS Bio (now Cerba), a French Diagnostics company. Vincent is a Founding Partner of ARCHIMED, and is President of the EURÊKA Foundation, ARCHIMED'S charitable foundation. Vincent has a long-standing relationship with other ARCHIMED partners, since 2005. He is currently a non-executive Director in the France-headquartered Neuro-Diagnostic company Micromed, in the Austria-headquartered In-Vitro Diagnostics specialist EuroLyser, in the UK-headquartered Occupational Health firm Vita Health and in the Italy-headquartered In-Vitro Diagnostics player Diesse. Vincent also was a non-executive Director of France-headquartered Health Ingredients firm Natural Origins (formerly Herbs’ International Services – HIS, Italy-headquartered Dental company Primo and in the Switzerland-headquartered Trauma Orthopaedics company Medistream / Citieffe. Vincent leads the MED (smallcap) funds of ARCHIMED. Vincent is a member of ARCHIMED'S Management Committee.
At ARCHIMED, we commit to providing strategic and tactical assistance, in addition to expanded financial capabilities, to the companies we partner with. We have a deep understanding and robust expertise within the Healthcare market and many members of our team have a thorough and differentiated scientific background. ARCHIMED'S diverse team bring strategic and operational insights, wide-ranging international experiences and extensive industry networks to our partner companies. Our healthcare industry knowledge is complemented by a breadth of experiences in global private equity and finance.
Vincent holds over 15 years experience in the Healthcare and Private Equity sectors. Vincent started his career at Bain & Company as a consultant before joining 3i’s Healthcare team. Prior to joining ARCHIMED, Vincent was the Managing Director of JS Bio (now Cerba), a French Diagnostics company. Vincent is a Founding Partner of ARCHIMED, and is President of the EURÊKA Foundation, ARCHIMED'S charitable foundation. Vincent has a long-standing relationship with other ARCHIMED partners, since 2005. He is currently a non-executive Director in the France-headquartered Neuro-Diagnostic company Micromed, in the Austria-headquartered In-Vitro Diagnostics specialist EuroLyser, in the UK-headquartered Occupational Health firm Vita Health and in the Italy-headquartered In-Vitro Diagnostics player Diesse. Vincent also was a non-executive Director of France-headquartered Health Ingredients firm Natural Origins (formerly Herbs’ International Services – HIS, Italy-headquartered Dental company Primo and in the Switzerland-headquartered Trauma Orthopaedics company Medistream / Citieffe. Vincent leads the MED (smallcap) funds of ARCHIMED. Vincent is a member of ARCHIMED'S Management Committee.
Pure-play Healthcare investor
At ARCHIMED, we commit to providing strategic and tactical assistance, in addition to expanded financial capabilities, to the companies we partner with. We have a deep understanding and robust expertise within the Healthcare market and many members of our team have a thorough and differentiated scientific background. ARCHIMED'S diverse team bring strategic and operational insights, wide-ranging international experiences and extensive industry networks to our partner companies. Our healthcare industry knowledge is complemented by a breadth of experiences in global private equity and finance.

Denis has over 20 years of experience in the Healthcare sector. Denis started his career as a veterinarian and subsequently worked for AT Kearney as a consultant. In 2001, Denis joined Private Equity leader 3i as head of the Healthcare team, managing the company’s investments and portfolio assets across Europe, North America and Asia. Denis has actively contributed to the development and strategic growth of companies in various Healthcare sectors. He has served as a Board Member for over 15 public and private healthcare companies, including Quintiles, Labco, iPP, Vétoquinol, Neftys Pharma, Carso, Bioprofile and Cair. Denis is a member of the Healthcare taskforce of the Institut Montaigne, a pioneering independent French think tank. Denis is a Founding Partner of ARCHIMED. He is also a Director of the EURÊKA Foundation, ARCHIMED'S charitable foundation. Denis graduated from Vet Agro Sup, the French Veterinary University of Lyon and holds an MBA from HEC Paris. Denis speaks fluent English.

About ARCHIMED
ARCHIMED is an independent investment firm specialized in the Healthcare industry. ARCHIMED is a strategic and financial partner to European and North American companies operating in the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Consumer Health, Public Safety and Care Services sectors. ARCHIMED's international team comprises of individuals with investment, medical, scientific, technological and operational experiences. ARCHIMED works alongside healthcare entrepreneurs to accelerate their business growth, through internationalization, product and service range expansions as well as capacity extension, both organically (innovation) and through acquisitions. ARCHIMED's partnering companies and entrepreneurs leverage ARCHIMED's industry networks throughout the world. Over the last thirty years, ARCHIMED's leadership team has directly managed and invested in over forty small, medium and large-size healthcare companies throughout the world. ARCHIMED is committed to the improvement of Health outcomes both through its support for the Healthcare industry and through the EURÊKA Foundation, which is a direct beneficiary of its returns on investment.


We use cookies to offer you a better experience, analyze site traffic, and serve targeted advertisements. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.